CIRCULATING TUMOR CELL ENUMERATION PRODUCT

Information

• Research Project
• 8181919

• ApplicationId

  8181919

• Core Project Number

  261201000065C-0-0-1

• Full Project Number

  261201000065C-0-0-1

• Serial Number

  0

• FOA Number

• Sub Project Id

• Project Start Date

  9/30/2010 - 14 years ago

• Project End Date

  6/29/2011 - 13 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2010

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• Epic Science, Inc.

This project was funded as a Phase I contract by the NCI Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Program in response to funding announcement number 272 "Point of Care Analysis of Circulating Tumor Cells for Cancer Diagnostics, Prognosis, and Treatment."Circulating tumor cells (CTCs) are cancer cells that shed from either the primary tumor or its metastases and are circulating in the peripheral blood. While metastases are directly responsible for the majority of cancer deaths, CTCs may constitute seeds for metastases and are instrumental for the spread of the disease. Therefore the development of CTC-related applications is very important.

IC Name

• Activity

  N43

• Administering IC

  CA

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  200000

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  394

• Ed Inst. Type

• Funding ICs

  NCI:200000\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  EPIC SCIENCES, INC.

• Organization Department

• Organization DUNS

  829863294

• Organization City

  SAN DIEGO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  921211107

• Organization District

  UNITED STATES